BridgeBio Pharma (BBIO) News Today $51.21 -1.39 (-2.64%) Closing price 09/12/2025 04:00 PM EasternExtended Trading$52.71 +1.50 (+2.93%) As of 09/12/2025 07:06 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock BBIO Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent September 2025 August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 Time Period BridgeBio Pharma (BBIO) Gets a Buy from Piper SandlerSeptember 12 at 12:04 PM | theglobeandmail.comPfizer, Alnylam earn BridgeBio ire over sales tactics for amyloidosis drugs: BloombergSeptember 12 at 12:04 PM | msn.comFred Alger Management LLC Invests $982,000 in BridgeBio Pharma, Inc. $BBIOSeptember 12 at 5:20 AM | marketbeat.comWoodline Partners LP Trims Holdings in BridgeBio Pharma, Inc. $BBIOSeptember 11 at 6:49 AM | marketbeat.comZimmer Partners LP Has $10.42 Million Stock Holdings in BridgeBio Pharma, Inc. $BBIOSeptember 11 at 6:48 AM | marketbeat.comBridgeBio Pharma, Inc. $BBIO Stock Position Cut by Exome Asset Management LLCSeptember 11 at 6:03 AM | marketbeat.comFinancial Analysis: BridgeBio Pharma (NASDAQ:BBIO) vs. Assembly Biosciences (NASDAQ:ASMB)September 11 at 2:19 AM | americanbankingnews.comBridgeBio Pharma (NASDAQ:BBIO) CEO Neil Kumar Sells 40,000 SharesSeptember 10, 2025 | marketbeat.comBridgeBio Pharma (NASDAQ:BBIO) Director Sells $3,933,840.00 in StockSeptember 10, 2025 | marketbeat.comBridgeBio Pharma Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)September 10, 2025 | globenewswire.comBridgeBio Pharma, Inc. (BBIO) Autosomal Dominant Hypocalcemia Type 1 (ADH1) Investor Webinar Call (Transcript)September 10, 2025 | seekingalpha.comAutosomal Dominant Hypocalcemia Type 1 (ADH1) Investor Webinar PresentationSeptember 10, 2025 | seekingalpha.comBaird Financial Group Inc. Purchases New Position in BridgeBio Pharma, Inc. $BBIOSeptember 10, 2025 | marketbeat.comNeil Kumar Sells 40,000 Shares of BridgeBio Pharma (NASDAQ:BBIO) StockSeptember 9, 2025 | insidertrades.comCritical Analysis: BridgeBio Pharma (NASDAQ:BBIO) versus Teva Pharmaceutical Industries (NYSE:TEVA)September 9, 2025 | americanbankingnews.comBridgeBio Pharma, Inc. (BBIO) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference (Transcript)September 8, 2025 | seekingalpha.comBridgeBio Pharma (BBIO): Assessing Valuation After Strong Encaleret Data and Pipeline AdvancesSeptember 8, 2025 | finance.yahoo.comPhilosophy Capital Management LLC Takes $13.54 Million Position in BridgeBio Pharma, Inc. $BBIOSeptember 8, 2025 | marketbeat.comAlliancebernstein L.P. Trims Stock Position in BridgeBio Pharma, Inc. $BBIOSeptember 8, 2025 | marketbeat.comAdage Capital Partners GP L.L.C. Acquires 246,555 Shares of BridgeBio Pharma, Inc. $BBIOSeptember 8, 2025 | marketbeat.comBridgeBio announces results from Phase 2 study of encaleretSeptember 7, 2025 | msn.comBosun Asset Management LLC Takes Position in BridgeBio Pharma, Inc. $BBIOSeptember 7, 2025 | marketbeat.comEncaleret Showed Parathyroid Hormone-Independent Normalization of Blood and Urine Calcium in Phase 2 Proof-of-Concept Study in Post-Surgical HypoparathyroidismSeptember 6, 2025 | globenewswire.comDuquesne Family Office LLC Purchases Shares of 438,050 BridgeBio Pharma, Inc. $BBIOSeptember 6, 2025 | marketbeat.comBridgeBio Pharma, Inc. $BBIO Shares Bought by Cormorant Asset Management LPSeptember 6, 2025 | marketbeat.comBridgeBio Pharma, Inc. $BBIO Shares Sold by Cutter Capital Management LPSeptember 6, 2025 | marketbeat.comBridgeBio Pharma (NASDAQ:BBIO) and Targeted Medical Pharma (OTCMKTS:TRGM) Head to Head AnalysisSeptember 6, 2025 | americanbankingnews.comBridgeBio Pharma (NASDAQ:BBIO) Given New $70.00 Price Target at JPMorgan Chase & Co.September 6, 2025 | americanbankingnews.comJPMorgan Chase & Co. Forecasts Strong Price Appreciation for BridgeBio Pharma (NASDAQ:BBIO) StockSeptember 5, 2025 | marketbeat.comAllostery Investments LP Invests $2.77 Million in BridgeBio Pharma, Inc. $BBIOSeptember 5, 2025 | marketbeat.comIeq Capital LLC Makes New $931,000 Investment in BridgeBio Pharma, Inc. $BBIOSeptember 5, 2025 | marketbeat.comBridgeBio Pharma (BBIO) Receives a Rating Update from a Top AnalystSeptember 3, 2025 | theglobeandmail.comHBK Investments L P Buys New Stake in BridgeBio Pharma, Inc. $BBIOSeptember 3, 2025 | marketbeat.comBridgeBio to Host Autosomal Dominant Hypocalcemia Type 1 (ADH1) Investor Webinar on Wednesday, September 10th at 8:00 am ETSeptember 3, 2025 | globenewswire.comQuarry LP Makes New Investment in BridgeBio Pharma, Inc. $BBIOSeptember 3, 2025 | marketbeat.comBridgeBio to Present Phase 2 Proof-of-Concept Data for Encaleret in Post-Surgical HypoparathyroidismSeptember 2, 2025 | globenewswire.comPanagora Asset Management Inc. Has $21.30 Million Holdings in BridgeBio Pharma, Inc. $BBIOSeptember 2, 2025 | marketbeat.comComerica Bank Sells 22,425 Shares of BridgeBio Pharma, Inc. $BBIOSeptember 2, 2025 | marketbeat.comHsbc Holdings PLC Reduces Position in BridgeBio Pharma, Inc. $BBIOSeptember 2, 2025 | marketbeat.comDriehaus Capital Management LLC Makes New Investment in BridgeBio Pharma, Inc. $BBIOAugust 31, 2025 | marketbeat.comRafferty Asset Management LLC Sells 48,114 Shares of BridgeBio Pharma, Inc. $BBIOAugust 31, 2025 | marketbeat.comTema Etfs LLC Raises Stock Position in BridgeBio Pharma, Inc. $BBIOAugust 30, 2025 | marketbeat.comAcoramidis Demonstrates Statistically Significant Reduction in Cardiovascular Mortality (CVM) through Month 42 of the ATTRibute-CM Open Label ExtensionAugust 30, 2025 | globenewswire.comFORA Capital LLC Makes New Investment in BridgeBio Pharma, Inc. $BBIOAugust 30, 2025 | marketbeat.comBridgeBio Pharma, Inc. $BBIO Shares Bought by Price T Rowe Associates Inc. MDAugust 30, 2025 | marketbeat.comNorthern Trust Corp Has $44.49 Million Stock Holdings in BridgeBio Pharma, Inc. $BBIOAugust 30, 2025 | marketbeat.comWill New 42-Month Acoramidis Data at ESC 2025 Reshape BridgeBio Pharma's (BBIO) Outlook?August 30, 2025 | finance.yahoo.comHere’s What Wall Street Thinks About BridgeBio Pharma (BBIO)August 29, 2025 | finance.yahoo.comBridgeBio Pharma, Inc. $BBIO Shares Acquired by Affinity Asset Advisors LLCAugust 28, 2025 | marketbeat.comBridgeBio to Participate in September Investor ConferencesAugust 27, 2025 | globenewswire.com Get BridgeBio Pharma News Delivered to You Automatically Sign up to receive the latest news and ratings for BBIO and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. BBIO Media Mentions By Week BBIO Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. BBIO News Sentiment▼0.890.92▲Average Medical News Sentiment BBIO News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. BBIO Articles This Week▼2511▲BBIO Articles Average Week Get the Latest News and Ratings for BBIO and Related Stocks Enter your email address to receive the latest news and analysts' ratings for BridgeBio Pharma and its competitors. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Companies and Tools Related Companies BeOne Medicines News Insmed News BioNTech News Teva Pharmaceutical Industries News Summit Therapeutics News Genmab A/S News Ascendis Pharma A/S News Viatris News Dr. Reddy's Laboratories News QIAGEN News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:BBIO) was last updated on 9/14/2025 by MarketBeat.com Staff From Our PartnersTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | SponsoredExpert Alert: Massive Bubble Could Crash Your WealthOn July 4th, Trump signed the “One Big Beautiful Bill,” adding $3.4 trillion to the national debt — and pushin...American Alternative | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredWhat President Trump’s Executive Order 14154 means for your moneyA new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredApple’s falling behindApple just posted record-breaking results, yet its stock barely moved — because in today’s market, investors o...Porter & Company | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | Sponsored$15 Fund: Turn Gold Boom into Real IncomeIf you've been watching gold's historic run and wondering if it's too late… I've got good news. Because the...Investors Alley | SponsoredThe $17B signal no one expected…After SpaceX struck a $17 billion deal with EchoStar for a block of radio frequencies, tech analyst Jeff Brown...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding BridgeBio Pharma, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share BridgeBio Pharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
